New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

Published Aug 26, 2020

New Targeted Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back

RET+ lung cancers are aggressive and have a poor prognosis, but new targeted drug selpercatinib (Retevmo) benefits more than 90% of patients who have this type of cancer.

NOW
PLAYING
$21 Billion Bet On Cancer Drug Trodelvy: What Does It Mean for Patients?
NOW
PLAYING
It's Not a Smokers' Disease — Anyone Can Get Lung Cancer
NOW
PLAYING
Revolution in Lung Cancer Drugs Extends Life
NOW
PLAYING
Comprehensive Biomarker Testing for Lung Cancer Points Docs to the Right Drug
NOW
PLAYING
Is Medical Marijuana Right for People With Lung Cancer?
NOW
PLAYING
You Found Out You Have Lung Cancer: Your Next Steps Are Important
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.